Review
Open access
Oct 2026
Subtype-Specific Aptamer Technologies for Breast Cancer: From Molecular Recognition to Precision Applications
Breast-cancer management depends on reproducible molecular classification, yet tissue-based assays provide only spatially and temporally restricted views of a heterogeneous disease. Aptamers are programmable single-stranded DNA or RNA ligands that can integrate molecular recognition with biosensing, liquid-biopsy captu...
Hui-Bin Wu, Zhi Zeng, Wen-Yi Huang et al.
· Biosensors · 0 citations